EmergingMarketWatch (formerly CEEMarketWatch) offers a unique EM research product, which over the past decade has become a primary source for nearly all major investment banks. Our coverage blends the speed and detail of newswires with the knowledge and insight of our local economists. We provide extensive daily coverage of over 60 emerging markets and periphery euro area countries tailored to the needs of economists and fund managers.
We cover extensively macroeconomic developments, providing a meaningful summary, background, and interpretation of the data. This is combined with our view of key economic developments, which is often influenced by local expertise and may differ from the consensus. We pay close attention to politics, and about 30% of our notes are political. Our political analysis is especially valuable in smaller economies where local politics is complex and often undercovered.
Our core clients are EM desks at large investment banks, the majority of which subscribe to our services. We have grown our client base over the years to include buy-side firms, government organizations and IFI's, and rating agencies. With the introduction of MIFID II, we have seen greater demand for our services from buy-side firms as it is an attractive alternative to bank research. Our product is most useful to people with a professional interest in a country, including economists, strategists, portfolio managers, and macro traders.
Large investment banks have traditionally been our core clients. For many years now, economists and strategists have read our report first thing in the morning for an overview of market-moving events. We believe our product suits their needs well because:
- We produce detailed reports, often at the speed of newswires
- We cover a wide range of countries in great detail and have built extensive expertise in local politics
- We provide access to our analysts for unlimited questions at no extra charge.
We believe that a free trial for our services can be considered a minor non-monetary benefit under MIFID II. The regulation limits the trial to three months for buy-side firms and it should not begin within 12 months of termination of a prior arrangement for research.
We will contact you shortly after submitting the form. Only trials with a legitimate corporate e-mail address will be activated.